Lempo Therapeutics

9:30 AM - 9:45 AM (EDT), Wednesday, October 23, 2019 ・ 2nd Floor
Lempo Therapeutics is a pre-clinical stage startup company developing a novel treatment for Pulmonary Arterial Hypertension, a fatal orphan disease, and a major unmet clinical need. Lempo patented treatment is based on stem cell gene editing and is also applicable to major neurodegenerative diseases (AD, PD, MS).
The co-founders' personal story leading to founding Lempo deserves an independent presentation :)
Company Type:
Company Website:
Company HQ State:
Not Provided
Company HQ Country:
Israel
Year Founded:
2017
Main Therapeutic Focus:
Lead Product in Development:
MPO-001
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):
3